Triple IgE-positivity to hornet, wasp and bee venom in the patient with anaphylaxis: diagnostic and therapeutic approach
Scindeks Assistant Scindeks Assistant — A system for serious journals and those aspiring to become one
PDF

Abstract

Abstract

 

Introduction. Triple-positivity (TP) or double-positivity (DP) for serum-specific immunoglobulin E (sIgE) antibod­ies against hornet venom (HV), wasp venom (WV) and/or honeybee venom (BV) causes significant problem in a se­lection of appropriate venom immunotherapy. However, DP/TP can be caused by cross-reactions resulting either from partial sequence identity of protein allergens in the venoms, or may be related to cross-reacting carbohydrate determinants (CCDs). Case report. A 60-year-old man was stung by a wasp and two days later by hornet. In both cases, within 15 minutes he developed hypotension and general­ized urticaria and he was successfully treated with epineph­rine, corticosteroids and fluids. After eight weeks, the ex­amination revealed the negative skin prick test for all three venoms, but the sIgE-determination (ELISA, Biopharm) showed triple sensitization to native BV (0.55 IU/mL), WV (3.35 IU/mL) and HV (0.37 IU/mL). He was receiving the venom immunotherapy with venom mixtures for one year. In order to distinguish true multiple sensitization from cross-reactivity, the molecular-allergy testing by ImmunCAP with the CCD-free recombinant major allergens was per­formed. A high sensitization to Antigen 5-rVes v5 of WV (31.4 kU/L) was demonstrated while sIgE to phospholipase A2-rApi m1 of BV (0.15 kU/L) was negative; sIgE to CCD-MUXF3-bromelain (0.75 kU/L) explained the sIgE-positiv­ity for native BV. After these findings, a venom immuno­therapy only with WV was initiated. Conclusion. In our patient, triple-IgE-positivity to native venoms detected by the ELISA was caused by cross-reactivity to CCDs. We rec­ommend the molecular-allergy testing with the nonglycosy­lated recombinant allergens before starting the venom im­munotherapy in patients with multiple-sIgE-positivity to native Hymenoptera venoms.

Keywords

Array
Array
Array
Array
Array
Array
DOI: 10.2298/VSP160831144J

References

REFERENCES

Ollert M, Blank S. Anaphylaxis to insect venom allergens: role of molecular diagnostics. Curr Allergy Asthma Rep 2015; 15(5): 26.

Eberlein B, Krischan L, Darsow U, Ollert M, Ring J. Double posi-tivity to bee and wasp venom: improved diagnostic procedure by recombinant allergen-based IgE testing and basophil activa-tion test including data about cross-reactive carbohydrate de-terminants. J Allergy Clin Immunol 2012; 130(1): 155–61.

Müller UR, Johansen N, Petersen AB, Fromberg-Nielsen J, Haeberli G.Hymenoptera venom allergy: analysis of double positivity to honey bee and Vespula venom by estimation of IgE antibodies to species-specific major allergens Api m1 and Ves v5. Allergy 2009; 64(4): 543–8.

Bernstein IL, Li JT, Bernstein DI, Hamilton R, Spector SL, Tan R, et al- Allergy Diagnostic Testing: An Updated Practice Parameter. Annal Allergy Asthma Imunol 2008; 100 (3 Suppl 3): S1–148.

Niedoszytko M, Bonadonna P, Oude Elberink JN, Golden DB. Epi-demiology, diagnosis, and treatment of Hymenoptera venom allergy in mastocytosis patients. Immunol Allergy Clin North Am 2014; 34(2): 365–81.

Kucharewicz I, Bodzenta-Lukaszyk A, Szymanski W, Mroczko B, Szmitkowski M. Basal serum tryptase level correlates with se-verity of hymenoptera sting and age. J Investig Allergol Clin Immunol 2007; 17(2): 65–9.

Biló BM, Rueff F, Mosbech H, Bonifazi F, Oude-Elberink JN. EAACI Interest Group on Insect Venom Hypersensitivity. Diagnosis of Hymenoptera venom allergy. Allergy 2005; 60(11): 1339–49.

Ludman SW, Boyle RJ. Stinging insect allergy: current perspec-tives on venom immunotherapy. J Asthma Allergy 2015; 8: 75–86.

Tretter V, Altmann F, Kubelka V, März L, Becker WM. Fucose alpha 1,3-linked to the core region of glycoprotein N-glycans creates an important epitope for IgE from honeybee venom allergic individuals. Int Arch Allergy Immunol 1993; 102(3): 259–66.

Nittner-Marszalska M, Cichocka-Jarosz E. Insect sting allergy in adults: key messages for clinicians. Pol Arch Med Wewn 2015; 125(12): 929–37.

Sturm GJ, Jin C, Kranzelbinder B, Hemmer W, Sturm EM, Gries-bacher A, et al. Inconsistent results of diagnostic tools hamper the differentiation between bee and vespid venom allergy. PLoS One 2011; 6(6): e20842.

Hemmer W. Cross reactions between Hymenoptera venoms from different families, genera and species. Hautarzt 2014; 65(9): 775–9. (German)

Müller U, Schmid-Grendelmeier P, Hausmann O, Helbling A. IgE to recombinant allergens Api m 1, Ves v 1, and Ves v 5 distinguish double sensitization from crossreaction in venom allergy. Allergy 2012; 67(8): 1069–73.

Jappe U, Raulf-Heimsoth M, Hoffmann M, Burow G, Hübsch-Müller C, Enk A. In vitro hymenoptera venom allergy diagnosis: improved by screening for cross-reactive carbohydrate determinants and reciprocal inhibition. Allergy 2006; 61(10): 1220–9.

Carballada FJ, González-Quintela A, Núñez-Orjales R, Vizcaino L, Boquete M. Double (honeybee and wasp) immunoglobulin E reactivity in patients allergic to Hymenoptera venom: the role of cross-reactive carbohydrates and alcohol consumption. J Investig Allergol Clin Immunol 2010; 20(6): 484–9.

Hirata H, Yoshida N, Watanabe M, Sugiyama K, Arima M, Ishii Y. Sensitization of specific IgE-positive Japanese who have experienced Hymenoptera stings to recombinant versions of the Ves v 1 and Ves v 5 allergens in hornet venom. Allergol Int 2015; 64(1): 115–7.

Korošec P, Valenta R, Mittermann I, Celesnik N, Silar M, Zidarn M, et al. High sensitivity of CAP-FEIA rVes v 5 and rVes v 1 for diagnosis of Vespula venom allergy. J Allergy Clin Immunol 2012; 129(5): 1406–8.

Sturm GJ, Biló MB, Bonadonna P, Hemmer W, Caruso B, Bokanovic D, et al. Ves v 5 can establish the diagnosis in pa-tients without detectable specific IgE to wasp venom and a possible north-south difference in Api m 1 sensitization in Eu-rope. J Allergy Clin Immunol 2012; 130(3): 817; author reply 818–9.

Vos B, Köhler J, Müller S, Stretz E, Ruëff F, Jakob T. Spiking ve-nom with rVes v 5 improves sensitivity of IgE detection in pa-tients with allergy to Vespula venom. J Allergy Clin Immunol. 2013; 131(4): 1225–7, 1227.e1.

Antolín-Amérigo D, Moreno Aguilar C, Vega A, Alvarez-Mon M. Venom immunotherapy: an updated review. Curr Allergy Asthma Rep 2014; 14(7): 449.

Bonifazi F, Jutel M, Biló BM, Birnbaum J, Muller U; EAACI Interest Group on Insect Venom Hypersensitivity. Prevention and treatment of hymenoptera venom allergy: guidelines for clinical practice. Allergy 2005; 60(12): 1459–70

Downloads

Download data is not yet available.